Grey market premium
The grey market premium (GMP) is the amount by which shares of a company preparing for an initial public offering (IPO) are informally quoted above the IPO issue price in the unofficial market before their listing on a recognised stock exchange. It is commonly used by market participants in India as an informal indicator of investor sentiment and possible listing performance.
GMP is not an official stock exchange price and is not published or verified by the Securities and Exchange Board of India (SEBI). Grey market transactions take place outside recognised exchange trading systems and do not carry the same regulatory protections as transactions conducted through regulated securities markets.
Mechanism
Before an IPO is listed on a stock exchange, some market participants informally quote prices at which they are willing to buy or sell IPO-related shares or applications. The difference between the quoted grey market price and the IPO issue price is referred to as the grey market premium.
GMP may change according to perceived demand for the IPO, market conditions, expectations about the company's valuation, and the availability of shares or allotments in the unofficial market.
Calculation
The commonly used calculation is:
For example, if an IPO has an issue price of ₹200 per share and its reported grey market price is ₹240, the grey market premium is ₹40 per share.
The implied premium as a percentage of the issue price is:
In this example, the reported GMP is 20% of the issue price. This percentage is an informal indication of the premium being quoted in the grey market, not a guaranteed listing return.
Interpretation
Positive GMP
A positive GMP indicates that the reported grey market price is above the IPO issue price. It may reflect favourable expectations or perceived demand for the offering.
Zero GMP
A zero GMP indicates that the reported grey market price is approximately equal to the IPO issue price.
Negative GMP
A negative GMP indicates that the reported grey market price is below the IPO issue price. It may reflect weaker sentiment, concerns about valuation, or changing market conditions.
These interpretations are indicative only. GMP is not a comprehensive measure of an IPO's financial quality or long-term investment prospects.
Factors influencing GMP
Several factors may influence the reported grey market premium:
- Investor sentiment: Expectations about the company's business prospects and valuation can affect demand.
- IPO subscription levels: Reported demand from retail, non-institutional, and institutional investors may influence sentiment, although subscription levels and GMP measure different things.
- Company fundamentals: Revenue growth, profitability, debt, cash flows, and competitive position can affect investor expectations.
- IPO valuation: The issue price relative to earnings, assets, comparable companies, and growth prospects may influence perceived value.
- Market conditions: Broader equity-market movements, liquidity, and economic developments can affect expectations about listing performance.
- Supply and demand in the grey market: Informal trading activity and the availability of IPO-related positions can influence quoted premiums.
Limitations and risks
GMP has significant limitations as an investment indicator.
- Unofficial pricing: There is no recognised exchange that establishes or verifies the quoted GMP.
- Limited transparency: Information about transaction volumes, participants, and actual traded prices may be unavailable.
- Price volatility: Reported premiums can change rapidly before listing.
- Manipulation risk: Unverified or selectively reported quotations can create misleading impressions of demand.
- No guaranteed listing gain: The actual listing price may be higher or lower than the price implied by GMP.
- Limited investor protection: Informal transactions may lack the clearing, settlement, and dispute-resolution safeguards associated with regulated exchange trading.
In an order concerning Veerkrupa Jewellers Limited, SEBI described GMP as operating in an unregulated sphere of the securities market and highlighted the risks associated with opaque pre-listing trading practices.
GMP and IPO listing price
Market participants sometimes estimate a potential listing price by adding the reported GMP to the IPO issue price:
For an IPO priced at ₹200 with a reported GMP of ₹40, this method produces an indicative price of ₹240. However, this is only a rough calculation based on an unofficial quotation. It does not constitute a reliable forecast of the actual listing price.
The listing price is determined by trading on the stock exchange and may be affected by market conditions, investor orders, valuation expectations, and developments occurring after the GMP quotation was reported.
Grey market transactions
The Indian IPO grey market may involve informal transactions related to IPO applications or expected share allotments. Two terms commonly associated with this market are:
- Kostak rate: An agreed amount paid for an IPO application, generally irrespective of the number of shares ultimately allotted, subject to the terms of the private arrangement.
- Subject to sauda: An informal arrangement in which payment is conditional on the IPO application receiving an allotment.
These arrangements are separate from the official IPO application and allotment process. Their terms and enforcement may lack the protections available through regulated financial markets.
GMP and investment decisions
GMP is sometimes considered alongside an IPO's subscription figures, valuation, financial statements, business model, competitive position, use of proceeds, and risk disclosures. However, GMP alone cannot establish whether an IPO is appropriately priced or suitable for a particular investor.
Investors can obtain official information about an IPO from its offer document and disclosures made through recognised stock exchanges. SEBI advises investors to assess the relevant disclosures and risks rather than relying solely on unofficial market indications.